A30.0

Clinical Causes: Infection with *Mycobacterium leprae*, a slow-growing bacterium responsible for leprosy. Prolonged contact with untreated individuals who have leprosy. Genetic susceptibility that influences individual risk. Environmental factors, including living conditions and hygiene practices.

Key Symptoms: One or multiple irregularly shaped skin patches, often lighter or darker than surrounding skin. Usually painless and may feel numb or less sensitive to touch, heat, or cold. Lesions that may be flat or slightly raised. Minimal or no nerve involvement in initial stages. Lesions tend to be transient and may regress spontaneously.

Diagnosis Path: Diagnosis of indeterminate leprosy involves a combination of clinical evaluation and laboratory tests. A healthcare provider will often examine skin lesions and assess nerve involvement. Skin smears may be taken to detect *Mycobacterium leprae*, although they can often be negative in early stages. Skin biopsies can reveal characteristic changes, but in indeterminate cases, findings are usually minimal. Differential diagnosis may include other skin disorders, so clinical expertise is essential for accurate identification.

Treatment Protocols: Treatment strategies aim to eliminate the infection and prevent progression. For indeterminate leprosy, antimicrobial therapy may involve multi-drug regimens similar to those used for other forms of leprosy, often comprising rifampicin and dapsone. The duration of treatment depends on clinical response and provider evaluation. Close follow-up is important to monitor progression or resolution of lesions. Early treatment can lead to complete reversal of skin changes and prevent nerve damage.